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1. Introduction 
Capsule endoscopy (CE), which was invented to visualize the entire small intestine in a 
noninvasive manner was first described in 2000 (Iddan, 2000), was approved for adult patients 
in 2001 by Food and Drug Administration (FDA). More than 600,000 PillCam SB capsules, 
which is the first model for CE in the world, have been used worldwide since 2001 
(Nakamura, 2009). In pediatric patients, Seidman et al has first described the diagnostic value 
of CE (Seidman, 2002), and in 2003, FDA approved CE for pediatric patients ages 10 years and 
older. Emerging number of CE studies in children indicate the great demand for this 
population ( Tokuhara, 2010; de'Angelis, 2007; Atay, 2009; Fritscher-Ravens, 2009; Moy, 2009; 
Guilhon de Araujo Sant'Anna, 2005; Thomson, 2010; Ge, 2007; Postgate, 2009; Pinho, 2008; 
Shamir, 2007; Stiffler, 2003; Argüelles-Arias, 2004; Cohen, 2008 ), but performed number is 
relatively small (approximately 600, at the time of 2010) compared to adult cases (> 600,000), 
therefore, informations about indications, obtained results and risk of complications are not 
fully understood in pediatric patients. In pediatric patients, as well as in adults, CE is a first-
line of examination to evaluate the entire small intestine and provides evidence for the 
diagnosis to the suspected small bowel disease especially in obscure gastrointestinal bleeding 
(OGIB) and suspected inflammatory bowel disease (IBD), on the other hand, accumulated 
studies are extending the indication of CE to protein loss, growth failure, abdominal pain, 
suspected polyp or graft-versus-host disease (GVHD) and regular follow-up for the known 
small bowel diseases. In this review, we summarize and discuss the capsule endoscopy 
system, indication, limitation, and future perspective of CE in pediatric patients. 
2. General features of CE 
2.1 Capsule endoscopy system 
Capsule endoscopy system in children is almost same as that of adults. It is available to use 
a pediatric accessory kit with a recorder belt and sensor array, which are more appropriately 
sized for children (Fritscher-Ravens, 2009), on the other hand, CE, a PillCam SB capsule 
itself is the same type used by adults. The PillCam SB system has three components: a 
capsule endoscopy body, an external receiving antenna (consisting of eight sensor arrays) 
with attached portable hard disc drive (data recorder), and a customized PC workstation 
(RAPID: reading and processing images and data) with dedicated software for review and 
interpretation of images (Cave, 2004). CE is 26-mm long, 11-mm wide, weighs 3.4 g, records 
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images at a rate of 2 frames per second (fps), and has a battery life of about 8 hours. Image 
features include a 1400C field of view, 1:8 magnification, 1- to 30-mm depth of view, and a 
minimum size of detection of about 0.1mm. There is no capability of biopsy. After the 
patients ingest capsule, they can resume normal activities immediately, and are permitted to 
consume clear liquids and food at 2 h and 4 h thereafter (Tokuhara, 2010). 
2.2 Abnormalities assessed by CE 
CE visualizes various mucosal abnormalities such as ulcer, erosion, stricture, vascular 
anomaly, and mucosal protuberance such as polyp and tumor in pediatric patients as well 
as in adults (Table 1, Fig.1). In addition, Abnormal intestinal contents such as bleeding and  
 
Findings 
Ulcer Vascular anormalies
Redness Polyp
Erosion Stricture
Atrophy Bleeding
White villi Intestinal contents (ex. parasitic worm) 
Mass 
Diagnosed or suggested diseases
Crohn’s disease Celiac disease
Angiodysplasia Hemangioma
Lymphangiectasia
Meckel’s diverticula Lymphonodular hyperplasia
Peutz-Jeghers syndrome GVHD
Blue rubber bleb Parasitic worm
Table 1. Findings and diagnosed or suggested diseases by CE 
 
 
Fig. 1. CE findings. (a) Normal jejunum. (b) Longitudinal ulcer (black arrow). (c) Stricture 
with redness and ulcer (arrows). (d) Active bleeding. (e) White villi. (f) Stenosis with ulcer. 
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parasitic worm can be seen (Table 1). Those abnormalities are highly detectable in the entire 
small intestine, to some extent, CE provide supportive information for the presence of 
abnormalities in the esophagus, stomach and colon. Transit time of CE and analyzed 
pathway by the software will help to assess the localization of detected abnormality in the 
small intestine. In pediatric patients with suspected small intestinal disease, CE detect 
abnormal findings in 55% (286/523) of cases (Tokuhara, 2010; de'Angelis, 2007; Atay, 2009; 
Fritscher-Ravens, 2009; Moy, 2009; Guilhon de Araujo Sant'Anna, 2005; Thomson, 2010; Ge, 
2007; Argüelles-Arias, 2004; Pinho, 2008; Stiffler, 2003). Based on the detected abnormalities 
by CE in addition to the clinical and/or other laboratory informations, various small 
intestinal diseases are diagnosed or suggested, or further elucidated of their involvements of 
small intestinal lesions in known diseases (Table 1). 
2.3 Comparison with other modalities 
A previous study demonstrated that CE is superior to small-bowel radiography, computed 
tomography enterography (CTE), and colonoscopy with ileoscopy in the evaluation of adult 
patients with suspected CD (Dionisio, 2010). As well as adult patients, CE is more sensitive 
than radiological and standard endoscopic modalities in the detection of small bowel CD 
distribution, OGIB source, and presence of polyps in children (Thomson, 2007; Guilhon de 
Araujo Sant'Anna, 2005). In addition, because of its non-invasive approach, even if initial 
study is non-diagnostic, repeat CE may increase diagnostic yield (Tokuhara, 2010). Further, 
even if initial CE study is technically inadequate (poor visualization and/or not reaching 
colon), it is possible to repeat examination compared to the invasive conventional 
examination.   Almost at the same time with CE, double balloon enteroscopy (DBE), which 
is relatively a novel technique compared to the conventional examination, was developed to 
investigate the entire small intestine (Yamamoto, 2001). DBE can evaluate the small intestine 
as well as CE, but can gather biopsy specimens, and can carry out therapeutic procedures 
which are impossible by CE. In order to evaluate the entire small intestine, it is necessary to 
perform DBE 2 times with anterograde and retrograde routes. On the other hand, DBE often 
cannot visualize the entire small intestine. In regard to the application of DBE in children, 
previous studies reported the feasibility and usefulness of DBE in pediatric patients 
(Nishimura, 2010; Thomson, 2010; Leung, 2007). Another study described the successful use 
of DBE in 3 years old children with OGIB (Kramer, 2009). In regard to the differences in 
diagnostic accuracy and other advantages between CE and DBE, most of studies have 
concluded that CE was superior to the initial diagnosis but DBE was superior to treatment 
or histopathological diagnosis in adult patients with OGIB (Hadithi, 2006; Nakamura, 2006). 
In addition, lack of experience and expertise for smaller children are to be solved for the 
future extensive use of DBE in children (Leung, 2007). Thus it is expected that DBE is used 
in pediatric patient, but it is prefer that DBE is performed based on the screening by CE.  
2.4 Preparations for CE 
Generally, overnight fasting is used as a standard preparation for CE in pediatric patients 
(Tokuhara, 2010; Guilhon de Araujo Sant'Anna, 2005; Atay, 2009). Diagnostic yield of 
capsule endoscopy depends on the quality of visualization of the small bowel wall and 
complete passage through the small bowel. Some abnormalities such as angiodysplasias are 
sometimes hampered by residual intestinal contents. Thus, a bowel preparation is studied 
previously, and sodium phosphate (Niv, 2005) or polyethylene glycol (PEG) (Viazis, 2004; 
Dai, 2005) has been described to offer improved visualization of the small intestine in adults. 
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In pediatric patients, colonoscopic bowel preparation was reported to offer the most 
favorable preparation. On the other hand, evaluation of entire small intestine is sometimes 
not completed because of prolonged gastric emptying and limited battery life (< 8h). In 
pediatric patients, completion rate of CE in the entire small intestine varies from 69 – 89 % 
(Tokuhara, 2010; Guilhon de Araujo Sant'Anna, 2005; Atay, 2009; de'Angelis, 2007; Ge, 2007; 
Moy, 2009; Postgate, 2009). In order to improve the completion rate, mosapride citrate or 
laxatives are one of candidate to increase the ability to observe the entire small intestine, but 
there is no systematic study in regard to the use of mosapride or laxatives as a preparation 
drug for CE study in pediatric patients. In adults, a previous study (Wei, 2007) reported oral 
10mg mosapride citrate 1h before CE examination could accelerate the gastric emptying 
(13.5 min vs 34 min) and completion rate of small bowel examination ( 93.3 % vs 66.7 % ). In 
regard to the laxatives, a previous study (Franke, 2008) reported that a combination of 
bisacodyl and sodium phosphate significantly accelerated small bowel transit time (262 min 
±55min vs 287 min ± 97min) but had no effect on the visibility of CE. Taken together, in 
order to increase the completion rate of small intestine and carefully examine the mucosal 
abnormality such as angiodysplasias, mosapride or laxatives might be effective preparation 
drug for CE in addition to the overnight fasting as the standard method. 
3. Ages and indications for CE 
3.1 Age 
Accumulated studies confirmed that CE is safe and useful to children over 10 years of age 
(Tokuhara, 2010; Guilhon de Araujo Sant'Anna, 2005; Argüelles-Arias, 2004), and 
application to this age group is considered as appropriate as well as adult. On the other 
hand, it is still controversial to use CE for the children under 10 years of age. Several studies 
described that CE has high diagnostic yield to those patients under 10 years of age 
(de'Angelis, 2007; Atay, 2009; Fritscher-Ravens, 2009; Ge, 2007), and their small body size 
don’t relate to the risk of capsule retention, which is the most serious complication in this 
modality as described in the latter paragraph. In addition, there was no difference in the 
gastric and small intestinal passage time between adult and pediatric patients (Ge, 2007). In 
young children (1.5-8 yr), a previous study reported CE detected small intestinal pathology 
in 45% (37 of 83 patients) in whom their indications are gastrointestinal bleeding, suspected 
Crohn’s disease, abnormal pain, protein loss and malabsorption (Fritscher-Ravens, 2009). 
Because of no incidence of retention among those aged patients (1.5-7.9yr), CE is considered 
as feasible and safe down to the age of 1.5 yr. As another important aspect, swallowing of 
CE is unavoidable problem in small children. Based on the previous studies, most of 
pediatric patients (>10yr) can ingest CE (Tokuhara, 2010; Guilhon de Araujo Sant'Anna, 
2005). In regard to children > 4yr, 32% of children could ingest CE (Fritscher-Ravens, 2009). 
In case those young children cannot ingest capsule, endoscopic placement of the capsule 
into the duodenum is used (Bizzarri , 2005; Barth, 2004; Fritscher-Ravens, 2009). In the 
endoscopic placement, CE is released at the third part of the duodenum in order to prevent 
migration of CE back to the stomach (Bizzarri , 2005; Barth, 2004; Fritscher-Ravens, 2009). 
Some of devices are developed and reported (Orendain, 2010), on the other hand, mucosal 
injury by passage of device should be taken into consideration as a complication (Barth, 
2004; Fritscher-Ravens, 2009). As another potential risk regarding the age, complication 
associated with deep intravenous sedation and general anesthesia for the endoscopic 
placement should be taken into consideration. 
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3.2 Indications 
The indications for CE in pediatric patients are similar to that of adult patients; OGIB and 
suspected IBD are the major indications and suspected or known polyps such as Peutz-
Jeghers syndrome are the following well-studied indication (Table 2). Known CD is also 
well-studied indication, but needs attention before the use of CE because of a relative high 
risk of capsule retention as described later. Malabsorption, protein loss, recurrent abdominal 
pain, and growth failure are the other minor indications, but sometimes important rather 
than adult population because of importance of mental and physical growth in children. 
Celiac disease is one of major indication in adult of Western countries such as USA and 
Europe, but it is rarely included as indication in children. On the other hand, because of 
non-invasive method, CE can be used repeatedly thus has been applied to get information to 
evaluate the treatment of known small bowel disease. Further, CE can provide supportive 
information about further examination, for example, when a physician determine the route 
of double balloon enteroscopy (via anal or oral) to resect polyps or take biopsies.  
 
 
Total 
Rate 
Atay, 
2009 
Fritscher-
Ravens, 
2009 
de’Angelis, 
2007 
Moy, 
2009 
Guilhon de 
Araujo 
Sant'Anna, 2005 
Thomson,
2010 
Ge, 
2007 
Tokuhara, 
2000 
Age 8~21 1.5~7.9 1.5~18 ND 10~18 9.4~15.9 3~18 10~18 
n 509 207 83 87 46 30 28 16 12 
Indications 
IBD 285 (56) 172 (83) 20 (24) 32 (37) 19 (41) 20 (67) 16 (57) 0 (0) 6 (50) 
(Suspected IBD) 138 (27) 73 (35) 20 (24) 10 (11) 0 (0) 20 (67) 10 (36) 0 (0) 5 (42) 
(Known IBD) 147 (29) 99 (48) 0 (0) 22 (25) 19 (41) 0 (0) 6 (21) 0 (0) 1 (8) 
OGIB 94 (18) 15 (7) 30 (36) 21 (24) 7 (15) 4 (13) 6 (21) 9 (56) 2 (17) 
Polyps 55 (11) 2 (1) 0 (0) 33 (38) 11 (24) 6 (20) 3 (11) 0 (0) 0 (0) 
Abdominal pain 22 (4) 0 (0) 12 (14) 0 (0) 1 (2) 0 (0) 1 (4) 3 (19) 4 (33) 
Protein loss 13 (3) 1 (1) 9 (11) 0 (0) 1(2) 0 (0) 2 (7) 0 (0) 0 (0) 
Malabsorption 13 (3) 0 12 (14) 1 (1) 0 0 0 0 0 
Growth failure 5 (1) 0 0 0 5(10) 0 0 0 0 
Diarrhea 4 (1) 4 (2) 0 0 0 0 0 0 0 
Table 2. Indications for CE in pediatric patients. 
Indications were summarized based on the previous CE studies for pediatric patients, which 
included at least 10 CE examinations for suspected small intestinal diseases (Tokuhara, 2010; 
de'Angelis, 2007; Atay, 2009; Fritscher-Ravens, 2009; Moy, 2009; Guilhon de Araujo 
Sant'Anna, 2005; Thomson, 2010; Ge, 2007). We excluded the studies with limited 
indications (ex. abdominal pain alone). (   ), percentage. ND, not described. 
3.2.1 Chron’s disease or inflammatory bowel disease 
CE provides supportive evidence to diagnose or exclude small bowel CD. Thus, CE can be 
used in order to evaluate suspected CD or IBD, small bowel involvement of known CD, or 
follow-up of known small bowel CD. In adults, OGIB is the major indication rather than 
suspected IBD, however in children, suspected CD or IBD became the major indication (Table 
2). Although indication rate of suspected CD or IBD depends on the physicians’ protocol and 
criteria, in regard to the papers in which all of small intestinal disease are included as 
indication, indication rate for suspected IBD varies from 0%-67% and total indication rate is 
27%(138/509). If known CD or IBD are included, indication rate increase up to 56% (285/509) 
(Table 2). On the other hand, a previous study showed the indication rate of suspected CD as 
7.8% in adult patients (Rondonotti, 2010). Because a known CD increases a risk of capsule 
retention possibly caused by an intestinal stricture (Cheifetz, 2006; Moy, 2009; Atay, 2009), it is 
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recommended to avoid the use of CE for the evaluation of known CD in both adult and 
children. In regard to the diagnostic accuracy, the previous pediatric study elucidated that CE 
was a more effective diagnostic tool in established CD patients compared with small-bowel 
radiography, CTE, and push enteroscopy (Thomson, 2007). Further, CE provides evidence not 
only to diagnose a patient having CD but also exclude CD and discriminate CD from 
indeterminate colitis. The rate of diagnosis of CD in patients with suspected CD depends on 
the study, which was 12.5-70.6% in adult (Cheifetz, 2006; De Bona, 2006; Fireman, 2003), and 
50-55% in children (de'Angelis, 2007; Fritscher-Ravens, 2009; Guilhon de Araujo Sant'Anna, 
2005), thus criteria of suspected CD will be an important issue of concern.  
3.2.2 OGIB and chronic anemia 
Obscure gastrointestinal bleeding (OGIB) including chronic anemia is one of the major 
indication of CE in children as well as in adults (Table 2). In adults, a previous study 
showed the indication rate of OGIB as 43.4% (Rondonotti, 2010). Another study identified 
those patients of having significant findings; small bowel CD, angiodysplasia, Meckel's 
diverticulum, and rarely parasitic infection such as hookworm (Sriram, 2004). In regard to 
the previous studies in which all of small intestinal disease are included as indication, 
indication rate of OGIB in pediatric CE varies from 7.2%-56.2%, and a total indication rate is 
18.4% (94/509) (Table 2). In regard to the outcome of CE for the evaluation of source of 
OGIB, CD, polyp or polyposis and angiodysplasia are the most frequently detected source 
of OGIB in children (Table 3). Hemangioma, ulcerative jejunitis and Meckel’s diverticulum 
are also sometimes found in pediatric patients with OGIB.  In regard to the source of venous 
malformations, Turner syndrome, which caused by loss of part or all of an X chromosome, is 
important in the field of pediatrics. In Turner syndrome, an intestinal telangiectasia is 
described as an association with an estimated incidence of 7% (Eroglu, 2002) and cause 
obscure GI bleeding. A previous report described that CE well detected multiple 
angiectasias and 2 large telangiectasia in the small intestine of a Turner syndrome with 
OGIB (Nudell, 2006). CE can determine the size, the location, and the number of 
telangiectasias, therefore contribute to select medical, surgical, or endoscopic therapy. 
 
Findings  Rate (%) 
Total abnormal findings 69.3 
CD  9.3 
Polyp or polyposis 9.3 
Angiodysplasia  9.3 
Hemangioma*  6.7 
Ulcerative jejunitis 5.3 
Meckel’s diverticulum 4 
Non-specific bleeding lesions 4 
Multiple venous malformations 2.6 
Giant ileal lymphoid nodular hyperplasia 2.6 
Hemorrhagic gastroduodenopathy 2.6 
Asmotic ulcer, Cobble stone appearance, Reduplication of the intestine, NSAID-
induced mucosal lesions, Erosive gastroenteropathy, Ileal bleeding ulcer,  
Multiple small intestinal varices, Ileal stenosis, TAM 
1.3 
* includes Blue rubber bleb syndrome 
Table 3. Outcome of CE in 75 patients with OGIB. 
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As another option, CE provides helpful information in the diagnosis of OGIB in patients 
who was suffered from malignant diseases such as leukemia and received chemotherapy 
and cord-blood transplantation or bone marrow transplantation . Our recent study 
described that CE provided a real-time imaging without patient’s stress and played a 
significant role in the management of OGIB in the malignant disease (Tokuhara, 2010). 
Chronic malignant diseases, such as leukemia, sometimes require repeated evaluation of 
gastrointestinal bleeding, but repeated conventional endoscopy is stressful and invasive, 
especially for seriously ill patients. Thus, repeated CE evaluation was acceptable to these 
patients and did not cause undue physical or mental stress. CE increases patient compliance 
and can therefore provide real-time informations about changes in gastrointestinal mucosal 
lesions without invasive bowel preparation.  
3.2.3 Polyp or tumor 
Although polyps and tumors are commonly detected in adult patients, it is rare to detect 
malignant tumor in pediatric patients thus polyp is a main indication in children. Following 
the 2 major indications (suspected IBD and OGIB), polyp or polyposis are well-performed 
indication (Table 2). In regard to the papers in which all of small intestinal disease are 
included as indication, indication rate of polyps in pediatric CE was 11% (55/509) (0-38%) 
(Table 2). The purpose of CE for the patients with suspected polyposis is diagnosis, follow-
up, selection of route of endoscopy to resect polyp, or determine the necessity of 
laparotomy. Polyp is sometimes found in a patient with OGIB as an indication (Ge, 2007). 
As a known polyposis, Peutz-Jeghers syndrome (PJS), familial adenomatous polyposis 
(FAP), juvenile polyp, and Bannayan-Riley-Ruvalcaba syndrome have been reported. CE 
provided high diagnostic yield (100%, 5/5) to those pediatric patients with suspected 
polyposis (deAngelis, 2007). Another study  examined 6 pediatric patients with known 
polyposis (3 PJS, 2 multiple juvenile polyposis, and 1 familial polyposis) and demonstrated 
that CE had 100% concordance with previously performed imaging modalities, but CE had 
a higher sensitivity revealing 50% more polyps than observed with the traditional imaging 
studies (Guilhon de Araujo Sant'Anna, 2005). Among polyposis, hereditary polyposis 
syndromes including PJS and FAP are known to develop benign small bowel pathology and 
cancer, thus the follow-up for PJS and FAP is especially important.  
In regard to PJS, which is a rare autosomal dominant disorder characterized by 
mucocutaneous pigmentation and the hamartous polyps throughout the gastrointestinal 
tract, diagnosis is made by genetic analysis of STK11 gene mutation or 2 of the 3 clinical 
criteria: family history of PJS, hamarmatous polyps, and mucocutaneous pigmentation 
(Giardillelo, 2006). Intestinal polyps sometimes cause bleeding, anemia, and 
intussusceptions. Further, the patients with PJS have risk of malignancy including intestinal, 
breast, lung cancer in which average age of development of malignancy is the fourth decade 
of life (van Lier, 2010). Their first episode of manifestation also tend to occur during the first 
decade of life. Previous study revealed that 68% of children had undergone a laparotomy for 
bowel obstruction by the age of 18 years and many of these proceeded to a second 
laparotomy within 5 years (Hinds, 2004). Further, PJS sometimes need endoscopic removal 
of polyps or surgical treatment for bowel obstruction. Based on the accumulated studies, it 
has been recommended that endoscopic evaluation of the upper and lower gastrointestinal 
tract and imaging of the small bowel should be performed from the age of 8 years of earlier 
if symptoms are present (Hinds, 2004; Hyer, 2000). Therefore it is important to detect 
malignancies in an early phase and to remove polyps that may be premalignant and may 
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cause complications. In this regard, it is necessary to understand the size and localization of 
polyps in PJS. CE can evaluate the entire small intestine and contribute to select whether 
polyps should be observed or removed by upper endoscopy, colonoscopy, or double 
balloon enteroscopy. In comparison to conventional technique, a previous study 
demonstrated that CE detected significantly higher numbers of small-bowel polyps (at least 
1cm in diameter) than barium follow-through in adult PJS patients (Brown, 2006). In 
pediatric patients with PJS, CE significantly detected small polyps (<10mm), and was 
assessed as a feasible, safe, and sensitive tool for small bowel screening in patients with PJS 
(Postgate, 2009). Therefore, CE can be used as a first-line surveillance approach in PJS. 
In regar to FAP, which is an autosomal dominant condition with a defect in the APC gene on 
chromosome 5q21, if the patient was left untreated, there is a nearly 100% progression to 
colorectal cancer  by the age of 35–40 yr (Hyer, 2000). The diagnosis is confirmed by finding 
adenomas during flexible sigmoidoscopy, or more than four pigmented ocular fundus 
lesions based on indirect ophthalmoscopy carries a 100% positive predictive value. In FAP-
affected families with a known gene mutation, direct DNA genotypic analysis can 
determine whether a family member has the condition. In children with FAP, 
hepatoblastoma is important as complication rather than intestinal polyps (Aretz, 2006). 
Typical FAP is characterized by the occurrence of hundreds to thousands of colorectal 
adenomas. Adenomas usually appear within the second decade, and become symptomatic 
during the third decade of life. In the patients with FAP, they have high risk to develop 
duodenal adenoma and cancer, thus the duodenum and particularly the periampullary 
region is recognized as a major cause of morbidity and mortality. A previous CE study in 
adult patients with FAP reported that 76% of the patients with FAP with duodenal 
adenomas had additional adenomas in the proximal jejunum in addition to polyps in the 
distal jejunum or ileum, in contrast, in FAP patients without duodenal polyps, jejunal or 
ileal polyps occurred rarely (12%) (Schulmann, 2005). Thus, CE may be useful in selected 
patients with FAP. In children, the feasibility and usefulness of CE is not remarkable in FAP 
compared to PJS. It is necessary to accumulate further studies for FAP in children to 
evaluate the feasibility and usefulness of CE. 
3.2.4 Abdominal pain 
Several CE studies evaluated pediatric patients with abdominal pain. Based on the 
previous studies in which all of small intestinal diseases are included as indication, 
indication rate of abdominal pain in pediatric CE was 4% (20/509), varies from 0.0 % to 
33.0% depends on the studies (Table 2). As for usefulness of CE, it is controversial that 
abdominal pain can be an appropriate indication for CE. In adult patients, a previous 
study described 20 patients with chronic abdominal pain who were negative for extensive 
diagnostic workup, but no patients had clinically significant CE findings (Bardan, 2003). 
On the other hand, another study for adult patients demonstrated that abdominal pain 
with additional symptoms such as weight loss (>10% of body weight), inflammation 
shown by laboratory tests, chronic anemia, and suspected OGIB was associated with high 
diagnostic yield (May, 2007). In addition, another study applied to 16 patients with 
chronic abdominal pain without criteria for other gastrointestinal disorders and detected 
abnormal findings in 3 patients but in which only 1 patient, with additional symptom of 
weight loss, had relevant findings to abdominal pain in which ileal erosions and 
inflammation with a stricture which undetected by radiology (Spada, 2006). Based on 
previous studies in adult population, CE doesn’t provide diagnostic value against 
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abdominal pain itself, and strict patient selection on the basis of additional symptoms of 
signs is the key to increasing the field to capsule endoscopy in patients with chronic 
abdominal pain. In regard to children, a previous study reported that CE detected small 
bowel involvement in 1/10 patients with functional abdominal pain and most of patients 
don’t have the related organic etiology (Shamir, 2007). Another pediatric study described 
that 6/12 patients with abdominal pain had abnormal findings in which 3 with small 
bowel CD, 2 lymph nodular hyperplasia, and 1 blue rubber bleb syndrome, however it is 
undescribed whether those patients had additional symptoms or signs (Fritscher-Ravens, 
2009). CE evaluation for a patient with recurrent abdominal pain reported a self-resolving 
ileojejunal intussusceptions in the mid-small bowel (Thomson, 2007). Taken together, as 
well as adult patients, it is indicated that CE doesn’t provide diagnostic value against 
abdominal pain in children, but additional symptoms or signs may increase the demand 
of CE. On the other hand, in treating children with FAP, it is important to give the family 
the reassurance that no serious disease in present according to physical examination and 
laboratory examination. In this regard, CE provides supportive informations to exclude 
the significant small bowel involvement. In adults, celiac disease might be suggested by 
CE in patients with abdominal pain (Culliford, 2005), but there is no report in pediatric 
population. 
3.2.5 Protein loss 
Protein loss might be included as indication for CE. A previous study evaluated 9 patients 
as having protein loss as a main indication, and revealed, in spite of normal duodenal 
biopsies, 6/9 had abnormal findings in which 4 had lymphangiectasia and 2 had lymph 
nodular hyperplasia (Fritscher-Ravens, 2009). Protein loss originated from the gut is often 
found in children with protein-losing gastropathy such as Menetrier disease (Tokuhara, 
2007). In case of protein loss as an indication, lymphangiectasia is one of the most suspected 
and obtained result by CE. Several reports (Alkhouri, 2009; Tokuhara, 2010;Thomson, 2007) 
described 4 cases of protein loss were identified of having intestinal lymphangiextasia in 
pediatric patients. 
3.2.6 Others 
Malabsorption and growth failure are not main indication for CE, but CE sometimes 
contribute to evaluate those patients. A previous study (MoyL, 2009) reported that CE 
identified 4/7 pediatric patients with unexplained growth failure and normal small bowel 
series as having small bowel CD. In their study, 5/7 patients had positive anti-Saccharomyces 
cerevisiae antibodies (ASCA), a diagnostic serological marker for CD. In addition, 3 patients 
had growth failure with abdominal pain, 2 patients had growth failure with diarrhea and 
apthous ulcers, and 1 patient had a family history of CD. Thus, Growth failure with 
additional symptom might be included as an indication for CE. 
As an optional application, CE can be applied to evaluate the management of 
gastrointestinal diseases such as Henoch-Schonlein purpura (HSP) (Preud’Homme DL, 
2006) and GVHD (Silbermintz, 2006; Yakoub-Agha I, 2004). In HSP, sastrointestinal bleeding 
occurs in ~50% of children, and massive bleeding may occur (Katz, 1991). A previous report 
demonstrated that CE contributed to identify the extent of the small intestinal involvement 
of HSP and confirmed the efficacy of cyclophosphamide therapy in improving the 
gastrointestinal lesions (Preud’Homme DL, 2006). In regard to GVHD, a previous study 
reported that in an 8-yr old child following allogeneic hematopoietic cell transplantation 
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who developed large volume bloody diarrhea requiring multiple blood transfusions that 
was resistant to aggressive therapy for GVHD, CE provided significant information not 
provided by upper endoscopy and colonoscopy that allowed for successful treatment 
changes (Silbermintz, 2006). Another study (Yakoub-Agha I, 2004) in adults demonstrated 
that CE provided more significant findings than upper endoscopy in the diagnosis of 
intestinal GVHD. The diagnosis of intestinal GVHD is based upon histological findings in 
endoscopic mucosal biopsy specimens. Therefore, it is sometimes required to use 
colonoscopy and upper endoscopy in order to diagnose and evaluate the extent of GVHD, 
but these tools cannot provide the entire small bowel information. In this regard, CE can 
provide supportive information about small bowel involvement of GVHD and the unknown 
source of OGIB and the effect of treatment. While DBE might be superior approach to CE in 
certain cases, it is an inappropriate option for exhausted children undergoing 
chemotherapy. In this regard, CE evaluation is acceptable to these patients and does not 
cause undue physical or mental stress, thus repeated CE examination is available. 
4. Complications and contraindications 
4.1 Complications 
The most significant complication in the CE examination is capsule retention (Fig.2). 
Capsule retention is defined as having a capsule endoscope remain in the digestive tract for 
a minimum of 2 weeks (Cave, 2005). A preceding normal small-bowel series does not 
preclude subsequent CE retention. The reported capsule retention rate in a study of 900 
adult patients was approximately 0.7% (Barkin, 2002). It should be noted that there are 
potential risks of retention in CD, especially known CD. A previous study in adults 
(Cheifetz, 2006) revealed that CD is an potential risk of having the retention which is caused 
by unsuspected strictures, and retention was occurred in 13% (5 of 38) of patients with 
known CD , whereas in 1.6% (1 of 64) with suspected CD. When we reviewed previous CE 
studies of pediatric patients, which included at least 10 CE examinations for each patient, 
and found that 13 capsules had been retained in a total of 345 CE examinations giving an 
average frequency of capsule retention of 3.7% (range, 0–20%) (Table 4).  
 
 
Fig. 2. Capsule retention.  
Small bowel series showing a capsule retention at ileal stenoses in a 10-year-old girl with 
OGIB. After 2 months of retention, stenoses were surgically resected and a capsule was 
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removed. The patient was finally diagnosed as having non-specific multiple ulcers of small 
intestine (Tokuhara, 2010). 
As well as adult cases, in also pediatric patients, a previous study retrospectively 
demonstrated that the risk of retention was significantly high (37.5% ; 3/8) in known CD, 
whereas none of patients with other indications showed the retention(Atay, 2009) . When 
capsule retention happened, a risk of endoscopic or surgical removal might arise, although 
some reports described successful excretion of capsule after the corticosteroid therapy 
against gastrointestinal disease such as eosinophillic gastroenteropathy(Guilhon de Araujo 
Sant'Anna, 2005). As another severe insults related to capsule retention, a previous study 
described that adult patient with Crohn’s disease had a perforation after capsule endoscopy 
(Parikh, 2009). To decrease the risk of capsule retention and the following perforation, care 
should be taken in obtaining a history of problems with delayed gastric emptying, small 
bowel obstruction secondary to previous surgical changes, pyloric stenosis, Crohn disease, 
or Meckel diverticulum. 
 
 
Age/sex Indication Duration* Symptoms Outcome 
Diagnosis 
(Source) 
(Retention)  
Tokuhara, 2010 10y, F OGIB 2 months None 
Surgical ileal 
resection
(stricture) ** 
de’Angelis , 2007 
F CD 3 months None 
Spontaneous
excretion
CD 
7y, F OGIB 2 months None 
Surgical 
removal
Blinding 
ending loop 
Atay, 2009 
22y, M Known CD 2 y Unknown 
Passed after 
medication
(ND) 
13y, M Known CD 3 weeks 
Nausea, 
emesis
Passed after 
steroid use
(ND) 
Thomson, 2010 <16y CD 4 weeks ND 
Passed after 
steroid use
CD (ND) 
(Transit abnormality) 
Atay, 2009 16y, M Known CD 5 days 
Abdominal 
pain
Surgery (stricure) 
Guilhon de 
Araujo 
Sant'Anna, 2005 
ND 
Suspected 
IBD 
10 days None 
Passed after 
steroid use 
Eosinophilic 
enteropathy 
(stricture) 
Moy, 2009 5-15y 
1 suspected 
CD 
3 known 
CD 
ND 
Abdominal 
pain
Surgical 
removal
4 CD 
ND 
Abdominal 
pain
Surgical 
removal
ND 
Abdominal 
pain
Passed after 
steroid use
5 days 
Abdominal 
pain
passed 
Cohen, 2008 ND Known CD ND Ileal pouch 
endoscopic 
removal
ND, not described; *Duration of retention or transit abnormalities. ** The patient was finally diagnosed 
as non-specific multiple ulcers of small intestine. 
Table 4. Capsule retention or regional transit abnormalities with symptoms or abnormal 
findings. 
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A novel dissolvable patency capsule will soon be available as a potential screening tool for 
patients deemed to be a high risk for retention. A patency capsule, which similar in size to 
PillCam SB and dissolves spontaneously because it is composed of lactose, has been 
developed by Given Imaging to assess bowel patency and degree of stenosis (Nakamura, 
2008). If passage of the patency capsule is blocked, the capsule dissolves in 40-100h. The 
safety and efficacy of the initial model has been questioned (Gay, 2005), but recently, a new 
patency capsule model with a biodegradable body has been developed. The new patency 
capsule is a reliable indicator of functional patency in suspected or even known cases of 
intestinal stricture, and it can be used prior to conventional CE to predict and minimize the 
risk of retention and impaction (Banerjee, 2007).  
As another rare condition, a previous study reported that a patient having a nervous 
temperament showed the discomfort, headache, and low blood pressure 2 h after capsule 
ingestion (Tokuhara, 2010). Patient temperament might affect outcome, especially among 
children, thus when pediatric patients have a nervous temperament, patient preparation, 
and explanation of the possibility of adverse effects to their legal guardians might be 
necessary. 
4.2 Contraindications 
It is not recommended to use CE in patients with known or suspected gastrointestinal 
obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and 
profile, patients with cardiac pacemakers or other implanted electromedical devices. It is not 
generally recommended to use CE in patients with difficulty of swallowing, but based on 
the development of capsule replacement, it is considerable if the pediatric patient is 
considered to take a benefit by capsule endoscopy even by endoscopic replacement under 
general anesthesia There is no detailed limitation to use CE in small children but it is not 
recommended to use CE under 1.5yr or 10kg of body weight. 
5. Perspective 
Development of capsule endoscopy provides another 2 types of capsule endoscopies 
(PillCam ESO and PillCam COLON) which is for the esophagus and the colon, respectively 
(Eliakim, 2004; Saurin, 2007). The Pillcam ESO capsule differs from the small-bowel capsule 
in that it has a camera at both ends of the capsule and captures a total of 14 images per 
second (7 per second for each camera). The battery life of the Pillcam ESO is approximately 
20 minutes and is approved for esophageal imaging only. The FDA approved the Pillcam 
ESO in November 2004. PillCam ESO and PillCam COLON have been demonstrated of their 
feasibility and usefulness in adult patients with GERD and esophageal varices, and colonic 
neoplasia, respectively. Future application of PillCam ESO and PillCam COLON is expected 
also in pediatric patients. As another interest of issue, therapeutic interventions using a 
capsule endoscope, such as delivery of medication to specific disease sites, smaller size of 
CE, higher quality image, biopsy with remote control are expected in future CE.  
6. Conclusion 
Capsule endoscopy is a non-invasive and effective approach to investigate the entire small 
bowel intestine in the suspected small intestinal diseases of children compared to the 
conventional examination methods (Barium series, computed tomography, push 
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enteroscopy), and provide the evidence in the diagnosis and give the supportive 
informations to evaluate the effect of the treatment and the clinical course. On the other 
hand, a physician and a patient must be aware of that CE is a first-line of surveillance but 
not necessarily a perfect tool to diagnose or exclude a disease thus other examination such 
as double-balloon endoscopy might be needed for histological examination or resection of 
lesions. In addition, especially in known CE, there is a risk of capsule retention which might 
need endoscopic or surgical removal. In those patients who are unable to swallow the 
capsule, endoscopic replacement of capsule is available . Major diagnostic yield is expected 
in patients having indications of suspected IBD, OGIB, and suspected polyps. Abdominal 
pain, malabsorption, protein loss, and growth failure might be included as indication 
especially when they accompanied additional clinical or laboratory signs suggesting 
inflammation. Relatively small number of CE studies in children compared to adult, it needs 
further consideration to use CE in small children at least under 10 years of age as well as 
children over 10 years of age and adults, it is clear that clinical application of CE in pediatric 
population is extending and there is small children who had benefit by the use of CE. For 
the future, together with accumulation of clinical studies, further development of CE such as 
smaller size of CE which is appropriate to small children, increased quality of images, 
option of biopsy, remote control are expected.  
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As result of progress, endoscopy has became more complex, using more sophisticated devices and has
claimed a special form. In this moment, the gastroenterologist performing endoscopy has to be an expert in
macroscopic view of the lesions in the gut, with good skills for using standard endoscopes, with good
experience in ultrasound (for performing endoscopic ultrasound), with pathology experience for confocal
examination. It is compulsory to get experience and to have patience and attention for the follow-up of
thousands of images transmitted during capsule endoscopy or to have knowledge in physics necessary for
autofluorescence imaging endoscopy. Therefore, the idea of an endoscopist has changed. Examinations
mentioned need a special formation, a superior level of instruction, accessible to those who have already
gained enough experience in basic diagnostic endoscopy. This is the reason for what these new issues of
endoscopy are presented in this book of New techniques in Gastrointestinal Endoscopy.
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